US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
BriaCell Therapeutics Corporation (BCTXW)
BriaCell Therapeutics Corporation (BCTXW) ニュース

BCTXW

BriaCell Therapeutics (BCTXW)

BriaCell Therapeutics Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BCTXW

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	05 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/06/15	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/06/03	21 : 00	GlobeNewswire Inc.	BriaCell Presents Clinical Efficacy Data at ASCO 2024	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/30	21 : 00	GlobeNewswire Inc.	BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/28	21 : 00	GlobeNewswire Inc.	BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/24	21 : 58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/24	21 : 00	GlobeNewswire Inc.	BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/21	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/18	05 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/18	05 : 33	GlobeNewswire Inc.	BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/17	06 : 10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/15	21 : 00	GlobeNewswire Inc.	BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/04/24	21 : 00	GlobeNewswire Inc.	BriaCell Announces Oral and Poster Presentations at ASCO 2024	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/04/10	21 : 00	GlobeNewswire Inc.	BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/04/09	21 : 00	GlobeNewswire Inc.	BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/03/07	22 : 00	GlobeNewswire Inc.	BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/03/06	22 : 00	GlobeNewswire Inc.	BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/02/27	22 : 00	GlobeNewswire Inc.	BriaCell Provides Update on Alleged Illegal Trading of Public Securities	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/02/07	22 : 00	GlobeNewswire Inc.	BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/02/06	22 : 30	GlobeNewswire Inc.	Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/01/31	12 : 48	GlobeNewswire Inc.	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/01/04	22 : 45	GlobeNewswire Inc.	BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/28	22 : 55	GlobeNewswire Inc.	BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/20	22 : 40	GlobeNewswire Inc.	BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/06	23 : 31	GlobeNewswire Inc.	BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/06	23 : 00	GlobeNewswire Inc.	BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/11/30	21 : 00	GlobeNewswire Inc.	BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/11/03	21 : 31	GlobeNewswire Inc.	BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/25	22 : 15	GlobeNewswire Inc.	BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/20	22 : 15	GlobeNewswire Inc.	October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technology	NASDAQ:BCTXW	BriaCell Therapeutics Corporation

Showing the most relevant articles for your search:NASDAQ:BCTXW

1 2 3 4 次へ >>

Bank of America

Health Care Select Sector

BNP Paribas (QX)

Energy Select Sector SPDR

Financial Select Sector

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約